IntelGenx Reports Second Quarter 2019 Financial Results
SAINT LAURENT, Quebec, Aug. 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp.(TSX-V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today reported financial results for the second quarter endedJune 30, 2019.
- SAINT LAURENT, Quebec, Aug. 08, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp.(TSX-V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today reported financial results for the second quarter endedJune 30, 2019.
- 2019 Second Quarter Financial Summary:
Cash and short-term investments totaled$6.1 millionas atJune 30, 2019 compared to $3.7 million in Q2-2018
Received its first shipment of cannabis extract from Tilray, Inc. (NASDAQ:TLRY) (Tilray), providing sufficient quantities for ongoing R&D batch production of cannabis-infused VersaFilm. - Operating costs and expenses were $2.5 million for the second quarter of 2019, versus $2.4 million for the corresponding three-month period of 2018.
- IntelGenxwill host a conference call to discuss these 2019 second quarter financial results today onAugust 8, 2019, at4:30 p.m.